Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate
- PMID: 21126961
- PMCID: PMC3037702
- DOI: 10.1074/jbc.M110.196808
Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate
Abstract
Calcium levulinate (4-ketopentanoate) is used as an oral and parenteral source of calcium. We hypothesized that levulinate is converted in the liver to 4-hydroxypentanoate, a new drug of abuse, and that this conversion is accelerated by ethanol oxidation. We confirmed these hypotheses in live rats, perfused rat livers, and liver subcellular preparations. Levulinate is reduced to (R)-4-hydroxypentanoate by a cytosolic and a mitochondrial dehydrogenase, which are NADPH- and NADH-dependent, respectively. A mitochondrial dehydrogenase or racemase system also forms (S)-4-hydroxypentanoate. In livers perfused with [(13)C(5)]levulinate, there was substantial CoA trapping in levulinyl-CoA, 4-hydroxypentanoyl-CoA, and 4-phosphopentanoyl-CoA. This CoA trapping was increased by ethanol, with a 6-fold increase in the concentration of 4-phosphopentanoyl-CoA. Levulinate is catabolized by 3 parallel pathways to propionyl-CoA, acetyl-CoA, and lactate. Most intermediates of the 3 pathways were identified by mass isotopomer analysis and metabolomics. The production of 4-hydroxypentanoate from levulinate and its stimulation by ethanol is a potential public health concern.
Figures




Similar articles
-
Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate.Chem Res Toxicol. 2013 Feb 18;26(2):213-20. doi: 10.1021/tx3003643. Epub 2012 Dec 6. Chem Res Toxicol. 2013. PMID: 23171137 Free PMC article.
-
Interrelations between C4 ketogenesis, C5 ketogenesis, and anaplerosis in the perfused rat liver.J Biol Chem. 2009 Oct 9;284(41):27799-27807. doi: 10.1074/jbc.M109.048744. Epub 2009 Aug 8. J Biol Chem. 2009. PMID: 19666922 Free PMC article.
-
Metabolism of R-beta-hydroxypentanoate and of beta-ketopentanoate in conscious dogs.Am J Physiol. 1995 Mar;268(3 Pt 1):E446-52. doi: 10.1152/ajpendo.1995.268.3.E446. Am J Physiol. 1995. PMID: 7900792
-
Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.Basic Res Cardiol. 2000 Apr;95(2):75-83. doi: 10.1007/s003950050167. Basic Res Cardiol. 2000. PMID: 10826498 Review.
-
Peroxisomes and beta-oxidation of long-chain unsaturated carboxylic acids.Scand J Clin Lab Invest Suppl. 1991;204:33-46. doi: 10.3109/00365519109104593. Scand J Clin Lab Invest Suppl. 1991. PMID: 2042025 Review.
Cited by
-
ACAD10 and ACAD11 allow entry of 4-hydroxy fatty acids into β-oxidation.Cell Mol Life Sci. 2024 Aug 22;81(1):367. doi: 10.1007/s00018-024-05397-8. Cell Mol Life Sci. 2024. PMID: 39174697 Free PMC article.
-
Metabolomics and mass isotopomer analysis as a strategy for pathway discovery: pyrrolyl and cyclopentenyl derivatives of the pro-drug of abuse, levulinate.Chem Res Toxicol. 2013 Feb 18;26(2):213-20. doi: 10.1021/tx3003643. Epub 2012 Dec 6. Chem Res Toxicol. 2013. PMID: 23171137 Free PMC article.
-
Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver.J Biol Chem. 2014 Feb 28;289(9):5510-7. doi: 10.1074/jbc.M113.541110. Epub 2014 Jan 7. J Biol Chem. 2014. PMID: 24398675 Free PMC article.
-
4-Hydroxy-2(E)-nonenal (HNE) catabolism and formation of HNE adducts are modulated by β oxidation of fatty acids in the isolated rat heart.Free Radic Biol Med. 2013 May;58:35-44. doi: 10.1016/j.freeradbiomed.2013.01.005. Epub 2013 Jan 15. Free Radic Biol Med. 2013. PMID: 23328733 Free PMC article.
-
Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAs.J Lipid Res. 2014 Mar;55(3):592-602. doi: 10.1194/jlr.D045112. Epub 2013 Dec 23. J Lipid Res. 2014. PMID: 24367045 Free PMC article.
References
-
- Tischer R. G., Fellers C. R., Doyle B. J. (1942) J. Am. Pharmacol. Assoc. 31, 217–220
-
- Gordon B., Kough O. S., Proskouriakoff A. (1933) J. Lab. Clin. Med. 18, 507–511
-
- Kolvraa S., Gregersen N., Christensen E., Gron I. (1977) Clin. Chim. Acta 77, 197–201 - PubMed
-
- Williams M., Huijmans J. G., Duran M., de Klerk J. B., van Maldegem B. T., Poll-The B. T. (2007) Ned. Tijdschr. Geneeskd. 151, 1191–1196 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases